Why comp tables are key investment tools and why most tables for cannabis are wrong

Why comp tables are key investment tools and why most tables for cannabis are wrong
What inning is the US cannabis industry in? It's question we get from new investors often, so we've quantified it.
Cannabis stocks trading on NYSE & NASDAQ have 9-14X the volume of US stocks on TSX & OTC. Imagine volume in US names with legalization.
Here is the link to my article in MJBizDaily in which I discuss the common the reasons behind recent cannabis equity raises. Capital is available
The discount in US-focused cannabis stocks vs Canada-focused stocks is starting to reverse, at least on EV/S, following stronger than expected results in the US,
My article analyzing how tight capital markets and a changing regulatory outlook are derailing the Schwazze deals can be found here, as published in Marijuana